SocialClimb’s Regulatory Advantage: How Embracing HIPAA Created a Moat in Healthcare Marketing

SocialClimb’s Regulatory Advantage: How Embracing HIPAA Created a Moat in Healthcare Marketing

Most companies view regulatory compliance as a burden to be minimized. But in healthcare marketing, where HIPAA regulations govern every aspect of patient data, SocialClimb saw an opportunity to create a competitive advantage.

In a recent episode of Category Visionaries, CEO Ty Allen revealed how embracing HIPAA’s constraints enabled them to provide something their competitors couldn’t: precise marketing ROI data tied to actual patient outcomes.

“In order to actually see the patient data and see all of the HIPAA controlled components of a patient’s experience with a practice or a hospital, you have to sign a BAA Business Associate agreement,” Ty explains. “That agreement puts you at risk as an entity. If you lose that data or are breached, you have significant liability at that point.”

This liability causes most competitors to avoid the challenge entirely. “What we see is most agencies and many technology providers refuse to sign those agreements,” Ty notes. But SocialClimb took a different approach: “I understand it. I wish I didn’t have to sign all those agreements, but I do because of the way that my service works.”

This decision proved transformative. “Because of that, we can do something that most cannot do in healthcare,” Ty shares. “We can attribute marketing efforts all the way down to the patient, a list of patients acquired by each marketing tactic. And in many cases, we can also help the practice understand what the lifetime value is on those customers, what the customer acquisition cost really is.”

The timing of this strategy coincided with a crucial market shift. “Today, depending on the specialty, in some cases, 40% to 45% of the patients that are selecting to choose a specialist are doing what’s called self referral,” Ty explains. As patients increasingly choose healthcare providers based on marketing rather than traditional referrals, the ability to track marketing effectiveness becomes critical.

This advantage became particularly valuable as private equity began transforming healthcare practices. PE-backed organizations demand sophisticated metrics and ROI tracking. “We live in this space where we’re the guys who actually give them the data that makes them act more like a tech startup than it does a traditional healthcare practice,” Ty notes.

The impact on sales has been significant. “Since we can actually point to case studies where we can show what the ridiculous ROI numbers are when you use our tools and tactics, signing up customers is more a process of just helping them understand what they can do,” Ty explains. “It’s not a difficult sell.”

This approach has driven consistent growth. “We’ve always grown at more than 30% per year and our pace this year is well above that. So we’re a 40 plus percent annual growth SaaS business today,” Ty shares. The company recently introduced features enabling customers to “use predictive data to identify high value cases in their area and target those patients that will bring them more profitable revenue versus just any kind of revenue.”

Their success offers a valuable lesson for founders entering regulated industries: sometimes the biggest opportunities lie in embracing rather than avoiding regulatory constraints. By turning HIPAA compliance into a competitive advantage, SocialClimb has built a moat that competitors can’t easily cross while providing customers with data they can’t get elsewhere.

“We don’t have any competitors that actually compete with us across all those different layers,” Ty notes. “But in every layer there are multiple players that do a great job.” By embracing what others avoid, SocialClimb has created a unique position in healthcare marketing that continues driving growth.